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Viral respiratory infections, especially acute bronchiolitis, play a key role in the development
of asthma in childhood. However, most studies have focused on respiratory syncytial virus
or rhinovirus infections and none of them have compared the long-term evolution of single
versus double or multiple viral infections.
Objective
Our aim was to compare the frequency of asthma development at 6–8 years in children with
previous admission for bronchiolitis associated with single versus double or multiple viral
infection.
Patients & methods
A cross-sectional study was performed in 244 children currently aged 6–8 years, previously
admitted due to bronchiolitis between September 2008 and December 2011. A structured
clinical interview and the ISAAC questionnaire for asthma symptoms for 6-7-year-old chil-
dren, were answered by parents by telephone. Specimens of nasopharyngeal aspirate for
virological study (polymerase chain reaction) and clinical data were prospectively taken dur-
ing admission for bronchiolitis.
Results
Median current age at follow-up was 7.3 years (IQR: 6.7–8.1). The rate of recurrent wheez-
ing was 82.7% in the coinfection group and 69.7% in the single-infection group, p = 0.06.
The number of wheezing-related admissions was twice as high in coinfections than in single
infections, p = 0.004. Regarding the ISAAC questionnaire, 30.8% of coinfections versus
15% of single infections, p = 0.01, presented “wheezing in the last 12 months”, data that
strongly correlate with current prevalence of asthma. “Dry cough at night” was also reported
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more frequently in coinfections than in single infections, p = 0.02. The strongest independent
risk factors for asthma at 6–8 years of age were: age > 9 months at admission for bronchioli-
tis (OR: 3.484; CI95%: 1.459–8.317, p:0.005), allergic rhinitis (OR: 5.910; 95%CI: 2.622–
13.318, p<0.001), and viral coinfection-bronchiolitis (OR: 3.374; CI95%: 1.542–7.386,
p:0.01).
Conclusions
Asthma at 6–8 years is more frequent and severe in those children previously hospitalized
with viral coinfection-bronchiolitis compared with those with single infection. Allergic rhinitis
and older age at admission seem also to be strong independent risk factors for asthma
development in children previously hospitalised because of bronchiolitis.
Introduction
There is strong evidence that respiratory viruses play a key role in the development of asthma
in children. Classic studies by Sigurs et al. showed that respiratory syncytial virus (RSV) bron-
chiolitis, severe enough to require hospitalization, is a risk factor for asthma at the age of 7, 13
and 18 [1,2,3]. ng asthma at 6 years being more than four-fold higher compared with HRV-
negative cases [4,5]. Other studies have reported that early human metapneumovirus (hMPV)
infection during infancy is also an independent risk factor for the development of preschool
asthma [6]]. However, most studies have focused on RSV or HRV infections and only one of
thm has evaluated the long-term evolution of viral coinfections, although focused exclusively
on human bocavirus (HBoV) and HRV coinfections in 3 to 35 month-old children with their
first or second wheezing episode [7].
Our main objective was to compare the frequency of asthma and other respiratory symp-
toms, at 6–8 years of age, in children with previous admission with bronchiolitis associated
with viral co-infection versus simple viral infection.
Patients and methods
This is a substudy of an ongoing prospective investigation of respiratory tract infections in
children, approved by The Medical Ethics Committee.
Clinical assessment
Inclusion criteria were children 6–8 years of current age, with a previous hospitalization with
bronchiolitis at 0–24 months of age, between September 2008 and December 2011.
During the hospital stay a physician filled out a study-questionnaire with the following vari-
ables: age, sex, month of admission, clinical diagnosis, history of prematurity, need for oxygen
therapy–evaluated via transcutaneous oxygen saturation -, axillary temperature ( 38˚C),
presence of infiltrates and/or atelectasis in chest X-rays, administration of antibiotic therapy,
length of hospital stay, total white blood cell (WBC) count, C-reactive protein (CRP) serum
levels and blood culture results (for those cases where such tests were performed) and results
of the virological study.
Parents were contacted by phone between October 2016 and January 2017, and were
invited to take part in the study. A telephone interview based on a structured questionnaire
was performed, to obtain information on wheezing episodes, related hospital admissions,
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physician-diagnosed atopic dermatitis, allergic rhinitis, food allergy, use of bronchodilators
and maintenance medication for asthma. Information on pet contacts, parental smoking hab-
its, presence of allergy, eczema and asthma in first order family members (mother, father or
siblings) that had been diagnosed by a medical doctor was also recorded.
Furthermore, the present investigation used the ISAAC questionnaire for asthma symp-
toms for 6-7-year-old children, previously validated and translated to Spanish [8], which was
answered by parents over the phone.
The researchers were blinded to the status of the child when the interviews were performed.
Informed consent was obtained from parents or legal guardians. Exclusion criteria were refusal
to participate.
Virus detection
Specimens consisted of nasopharyngeal aspirates (NPA) that were taken from each patient at
admission. Each specimen was sent for virological investigation to the Respiratory Virus and
Influenza Unit at the National Microbiology Center (ISCIII, Madrid, Spain). NPAs were pro-
cessed within 24 hours after collection. Upon receipt, three aliquots were prepared and stored
at -70˚C. Both the reception and the NPA sample processing areas were separate from those
defined as working areas.
Polymerase chain reactions (PCR) methods for detection of sixteen respiratory
viruses. Three reverse transcription (RT)-nested PCR assays were performed to detect a total
of sixteen respiratory viruses. In these assays, the reverse transcription and first amplification
round were carried out in a single tube using the Qiagen OneStep RT-PCR kit (Qiagen). Influ-
enza A, B and C viruses were detected by using primer sets only to amplify influenza viruses in
a multiplex PCR assay as previously described [9]. A second multiplex PCR was used to detect
parainfluenza viruses 1 to 4 (PIV), human coronaviruses (CoV) 229E and OC43, enteroviruses
(EV) and HRV [10]. Presence of RSV A and B types, hMPV, HBoV and adenoviruses (AdV)
were investigated by a third multiplex RT-nested PCR-BRQ method [11] (S1 Table).
Clinical definitions
Bronchiolitis. All the classic criteria, present in an initial episode of acute onset expiratory
dyspnea with previous signs of viral respiratory infection—whether or not this was associated
to respiratory distress or pneumonia—were applied in diagnosing bronchiolitis [12].
The term recurrent wheezing was used to imply more than one episode of wheezing verified
by a physician.
The children who answered affirmatively to question 2 of the ISAAC questionnaire,
"wheezing in the last 12 months", being the one that in the validation studies has shown a bet-
ter correlation with the current prevalence of asthma, were considered to have asthma [13].
Allergic rhinitis. Was defined as rhinitis appearing at least twice after exposure to a par-
ticular allergen and unrelated to infection.
Viral coinfection. Was defined as the detection of more than one viral pathogen in the
same sample.
Statistical analysis
Continuous variables were described using mean and standard deviation. Categorical variables
were described using absolute and relative frequencies. Clinical characteristics of patients with
simple infections were compared with those associated with coinfections.
To compare qualitative variables, Chi2 test or Fisher’s exact test was used if there were5
items of data in a cell. For quantitative variables, as all of them followed a normal distribution,
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the means were compared using the Students´s T to compare two groups. A two-sided value of
P< 0.05 was considered statistically significant.
Multivariate stepwise logistic regression analysis was used to calculate the adjusted odds
ratios (OR) with 95% confidence intervals for estimating the association between different fac-
tors and asthma. All analyses were performed using the Statistical Package for the Social Sci-
ences (SPSS), Version 21.0.
Results
Of the 351 children previously admitted with bronchiolitis, with positive viral detection and
current age between 6 and 8 years, 244 (52 coinfections and 192 single infections) could be
located and agreed to participate in the study.
Clinical characteristics during admission for bronchiolitis are presented in Table 1. No sig-
nificant clinical differences could be detected between both groups, coinfections and single
infections, in terms of age at admission, gender, prematurity, fever, hypoxia or length of hospi-
tal stay. The most frequently identified viruses in single infections were: RSV (100, 52%), HRV
(29, 15%), hMPV (15, 8%), AdV (5, 2.6%) and HBoV (3, 1.6%). The most frequent coinfections
were RSV + HRV (15, 29%) and RSV + HBoV (12, 23%).
With respect to comparability between both groups, no differences were found between
coinfections and single infections regarding allergic rhinitis, atopic dermatitis or food allergy
(Table 2). Several possible hereditary and environmental factors for the development of recur-
rent wheezing or asthma were also evaluated. No differences were observed in the family his-
tory of asthma or atopy. Nearly one-third of children were exposed to tobacco smoke, with
similar percentages in both groups (Table 2).
Median current age at follow-up contact was 7.3 years (IQR: 6.7–8.1), with a slight predom-
inance of females (52.5%). The rate of recurrent wheezing was 82.7% in the coinfection group
and 69.7% in the single-infection group, p = 0.06, needing rehospitalization for wheezing 21%
and 29% respectively, p = 0.251. The number of wheezing-related admissions was twice as
Table 1. Clinical characteristics at admission of infants with bronchiolitis associated with viral coinfection versus single infection.
Clinical feature
Viral Coinfection N = 52 Single infection N = 192
P-value
Age* (months) 5.4 (4.1) 5.3 (5.7) 0.942
Male 29 (55.8%) 87 (45.3%) 0.180
Prematurity 6 (11.5%) 24 (12.6%) 0.842
Temperature > 37.9˚C 30 (57.7%) 91 (47.4%) 0.188
Hypoxia (SatO2<95%) 26 (50%) 121 (63.4%) 0.080
PICU admission 1(1.9%) 8(4.2%) 0.446
Abnormal X-ray 13 (34%) 55 (38%) 0.652
Antibiotic treatment 10 (19%) 26 (13.5%) 0.305
Highest temperature* 38.6 (0.6) 38.7 (0.5) 0.428
Leucocytes*;cells/mm3 13,638 (5,656) 14,038 (13,840) 0.892
C reactive protein*; mg/L 29 (22.3) 25.8 (31.1) 0.062
Days of hospital stay* 4.2 (2.8) 4.5(2.8) 0.457
Days of fever* 3.1 (2.0) 2.6 (1.8) 0.539
Days of hypoxia* 3.7 (2.6) 3.3 (2.7) 0.507
*Mean (Standard deviation)
PICU: paediatric intensive care unit.
https://doi.org/10.1371/journal.pone.0189083.t001
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high in coinfections than in single infections, p = 0.004. A similar percentage of children were
prescribed inhaled corticosteroids in both groups. However, montelukast was used more fre-
quently in coinfections than in simple infections, p = 0.01 (Table 3).
Regarding the ISAAC questionnaire answers, nearly 70% had “ever wheezed”, without sig-
nificant differences between both groups. However, 30.8% of coinfections versus 15% of single
infections, p = 0.01, presented “wheezing in the last 12 months”, data that strongly correlate
with current prevalence of asthma. “Dry cough at night” was also reported more frequently in
coinfections than in single infections, p = 0.02. The questions: “Wheezing during exercise?”
and “Ever had asthma?” were affirmatively answered with similar frequency in both groups.
(Table 4).
In the combined coinfection and single infection group, several possible hereditary and
environmental risk factors for asthma at the age of 6–8 were evaluated using a univariate analy-
sis (Table 5). The risk of asthma was increased in children previously hospitalized for bronchi-
olitis with viral coinfection (OR = 2.498; 95% CI: 1.229–5.077), in those who were older at the
Table 2. Evaluation of background factors in 52 children with viral coinfection bronchiolitis and 192 simple infection bronchiolitis.
BACKGROUND FACTOR
VIRAL COINFECTION N = 52 SINGLE INFECTION N = 192
P-value
Current age* (years) 7.4 (0.9) 7.4 (0.9) 0.799
Breast feeding 43(82.7%) 154(80%) 0.687
Atopic dermatitis 22(42.3%) 74(38.5%) 0.622
Food allergy 5(9.6%) 19(9.9%) 0.952
Allergic rhinitis 7(13.5%) 38(19.8%) 0.296
Asthma
Mother 2(3.8%) 22(11.5%) 0.102
Father 4(7.7%) 23(13.5%) 0.255
Siblings 7(13%.5) 18(9.4%) 0.389
Atopy
Mother 6(11.5%) 32(16.7%) 0.366
Father 6(11.5%) 27(14%) 0.637
Siblings 9(17.3%) 34(17.7%) 0.946
Smoking
Mother 16(30.8%) 46(24%) 0.317
Father 14(27%) 65(34%) 0.343
*Mean (Standard deviation)
https://doi.org/10.1371/journal.pone.0189083.t002
Table 3. Respiratory evolution in children with viral coinfection versus single infection bronchiolitis.
VIRAL COINFECTION N = 52 SINGLE INFECTION N = 192 P-value OR (CI 95%)
Recurrent wheezing 43 (82.7%) 134 (69.7%) 0.060 2.068 (0.946–4.519)
Wheezing-related admissions 11 (21%) 56 (29.2%) 0.251 0.652 (0.313–1.358)
Number of wheezing-related admissions 4.4 (2.1) 2.2 (1.6) 0.004
Asthma treatment 25 (48%) 68 (35.4%) 0.090 1.688 (0.909–3.136)
Budesonide 14 (27%) 46 (24.2%) 0.688 1.153 (0.574–2.315)
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time of admission (7.5 ± 8.4 months versus 4.8 ± 4.2 months, p = 0.04), and in those with atopic
dermatitis (OR = 1.899; 95% CI: 0.980–3.680), allergic rhinitis (OR = 4.139; 95% CI: 1.983–
8.639) and food allergy (OR = 3.077; 95%CI:1.222–7.749). Almost 32% of children who were
older than 9 months at admission, developed asthma at 6–8 years old, vs. 18% of those less
than 9 months, p: 0.05. The proportion of asthma in children admitted at> 12 months of age,
reached 52.4% vs. 17% in those hospitalized with less than 12 months, p< 0.001.
The risk factors in Table 5 with a p-value < 0.10 were entered in a stepwise logistic regres-
sion analysis to estimate which factors were independently related to the development of
asthma at 6–8 years. Age> 12 months at admission for bronchiolitis (OR: 7.389; 95%CI:
2.683–20.352, p<0.001), age> 9 months at admission for bronchiolitis (OR: 3.484; CI95%:
1.459–8.317, p:0.005), allergic rhinitis (OR: 5.910; 95%CI: 2.622–13.318, p<0.001), and viral
coinfection- bronchiolitis (OR: 3.374; CI95%: 1.542–7.386, p:0.01) were the strongest indepen-
dent risk factors for asthma at 6–8 years of age.
Table 4. Asthma symptoms according ISAAC questionnaire in 52 children with background of viral coinfection bronchiolitis and 192 single infec-
tion bronchiolitis.
ASTHMA SYMPTOMS VIRAL COINFECTIONN = 52 SINGLE INFECTION N = 192 P-value OR (CI 95%)
Ever Wheezing 39 (75%) 133 (69.3%) 0.422 1.331 (0.662–2.676)
Wheezing last 12 months 16 (30.8%) 29 (15%) 0.010 2.498 (1.229–5.077)
Limited speech due to wheezing 5 (9.6%) 4 (4.5%) 0.237 2.234 (0.572–8.725)
Ever had Asthma 10 (19.2%) 55 (28.6%) 0.173 0.593 (0.278–1.265)
Wheezing during exercise 4 (7.7%) 8 (4.2%) 0.297 1.917 (0.554–6.634)




Table 5. Univariate tests of possible risk factors for current asthma at age 6–8 years in the compiled
coinfection and single infection groups.
RISK FACTORS P- value Odds Ratio CI 95%
Viral coinfection 0.010 2.498 1.229–5.077
Age >12 months at admission <0.001 5.274 2.074–13.402
Age >9 months at admission 0.050 2.153 0.982–4.719
Atopic dermatitis 0.050 1.899 0.980–3.680
Allergic rhinitis <0.001 4.139 1.983–8.639
Food allergy 0.013 3.077 1.222–7.749
Prenatal tobacco exposure 0.080 1.916 0.917–4.001
Breast feeding 0.479 1.377 0.567–3.344
Prematurity 0.744 1.177 0.443–3.129
Day care attendance 0.862 0.940 0.468–1.889
Furred pets 0.656 0.846 0.405–1.767
Asthma mother 0.576 1.325 0.493–3.560
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Discussion
Our current study shows for the first time to our knowledge, that there is a strong and inde-
pendent association between severe bronchiolitis associated with viral coinfection and the
development of asthma at 6–8 years old.
Viral coinfections are usually detected in up to 30% of children with an acute respiratory
tract infection [14]. Our group, in previous studies, found viral coinfections in 22.8% of 318
infants less than 2 years old admitted with bronchiolitis [11] and in 35% of 2,993 children less
than 14 years old admitted with lower respiratory tract infection [15]. Our current results con-
firm that the most frequently identified viral coinfections are dual RSV-HRV and RSV-HBoV
infections. Results from cohort studies evaluating the severity of acute respiratory viral coinfec-
tions are conflicting. Our group previously found that clinical severity was associated mainly
with RSV infections, either alone or in combination with other viruses [15]. However, Asner
et al. [16] in a recent systematic review and meta-analysis found no differences in clinical dis-
ease severity between viral coinfections and simple infections, although an increased risk of
mortality was observed amongst preschool children with coinfections. They conclude that
large, prospective, well designed studies with objective outcomes are needed to better under-
stand the clinical significance of viral respiratory coinfections.
Regarding the role of early viral respiratory coinfections in the development of wheezing or
asthma, so far, no study evaluating this possible association has been published. Our results
confirm that recurrent wheezing and asthma are very common in the first years of life after a
severe bronchiolitis. But the likelihood of developing asthma was 2.5 times higher if bronchiol-
itis was associated with viral coinfection compared to single infections. In addition, the num-
ber of rehospitalizations for asthma was also significantly higher in coinfections than in single
infections, suggesting that coinfections are associated not only with more frequency of asthma
but also with greater severity.
The mechanism by which respiratory infections are associated with subsequent asthma is
not fully understood but the different inflammatory responses released after viral infections
seem to play a relevant role. The induction of a prevalent Th2-type response, with the produc-
tion of IL-4, IL-5, and IL-13, results in a less robust and less efficient reaction to the infection,
clinically presenting as increased disease severity and risk for future recurrent wheezing
[17,18]. Several reports showed that thymic stromal lymphopoietin (TSLP) is a key initiator of
allergic airway responses [19] and significant negative correlation has been described between
TSLP levels in induced sputum and FEV-1 in asthmatic children [20]. TSLP is secreted by
RSV-infected airway epithelial cells (AECs) to promote the activation of dendritic cells (DCs)
[21,22]. The activated DCs can then induce a Th2 cell polarization response in the lung, which
could contribute the development of asthma in RSV-infected individuals, as well as induction
of exacerbations in asthmatic RSV-infected patients. It has been suggested that the ability of
RSV to induce TSLP expression by AECs is responsible for the subsequent Th2 aspects of the
immune response [23]. Other recent studies performed in young children with HRV infection,
have also found higher levels of nasal TSLP [24,25].
On the other hand, various genetic studies in humans have identified both IL-33 and its
receptor ST2, as being key regulators in the development of asthma [26] and to have a strong
Th2- promoting ability in animal models of asthma [27]. IL-33 is responsible for the immuno-
pathophysiological response observed following neonatal RSV infection in mice. Its presence
in nasal aspirates of human infants with severe RSV, together with the finding that by blocking
the receptor of interleukin 33 in vivo [28], Th2 responses are greatly reduced, suggest it has a
role in disease severity and asthma [29]. Our findings, in a recent study conducted in hospital-
ized infants with bronchiolitis and in healthy controls, showed that nasal TSLP and IL-33 are
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detected more frequently in viral coinfections than in single infections. In addition, infants
with dual RSV+HRV infection were 9 times more likely to have detectable nasal TSLP and this
association was independent of other factors such as age or illness severity [30]. It is worth not-
ing that no patient with bronchiolitis but with negative viral detection had detectable levels of
nasal TSLP or IL-33, suggesting that the release of these proteins may be mediated by respira-
tory viruses.
It can be hypothesized that this stronger TSLP response after viral coinfection bronchio-
litis, could stimulate a vigorous production of Th2-associated effector cytokines, such as IL-4,
IL-5, IL-13, as was reported in asthmatic adults by Ying et al, that could be associated with
higher frequency of wheezing and asthma development later on [31]. As far as we know, only
Lukkarinen et al [7] have compared the systemic Th1-type, Th2-type and proinflammatory
cytokine profiles in young children with simple versus viral coinfection, being HRV and
HBoV1 the viruses involved. They included hospitalized children less than 35 months of age
with their first or second wheezing episode. They observed that wheezing children with HRV
had higher proinflammatory responses than did those with HBoV1 or those with coinfection
HRV+HBoV1, suggesting that HBoV1 may interfere with HRV-induced immune responses.
Furthermore, this immunological response was accompanied by the clinical finding that chil-
dren with HRV+HBoV1 wheeze tended to develop recurrent wheezing later and less often
than did those with HRV wheeze. Our previous and current results suggest that an interaction
may also occur in RSV and HRV coinfections, but in an opposite way, towards a predominant
Th2 response that could increase the development of recurrent wheezing/asthma.
The risk of asthma in our study, like in other cohort studies on hospitalized children with
lower respiratory symptoms, was directly dependent on age [4,32]: the adjusted OR was 3.4 for
asthma in children with bronchiolitis aged> 9 months and 7.3 for asthma in school age in
bronchiolitis children aged> 12 months. However, Lukkarinen et al [33], in a 7-year follow-
up found asthma inversely dependent on age, probably because they studied infants with
wheezing only, vs. bronchiolitis, with or without wheezing, in other studies as in ours. This dif-
ferent inclusion criteria may bias the kind of patients included in the studies.
Rhinitis is a known risk factor for asthma in children [34]. Our results suggest that rhinitis
is an independent risk factor for asthma persistence in school-age children with previous
severe bronchiolitis. Lauhkonen et al [35] in a prospective follow-up study, in 102 children
hospitalised for bronchiolitis, also found that current asthma was associated with prolonged
rhinitis and a positive skin prick test at five to seven years. On the other hand, recent reports
have demonstrated that the severity of rhinitis and asthma are closely related in children [36].
Thus, as other authors have stated [37], all these results highlight the convenience to assess
nasal symptoms in infants and children with recurrent wheezing and asthma.
In conclusion, asthma at the age of 6–8 is more frequent and severe in those children previ-
ously hospitalized with viral coinfection bronchiolitis compared with those with single infec-
tion. Moreover, viral coinfection, allergic rhinitis and older age at admission seem also to be
strong independent risk factors for asthma development in children previously hospitalised
because of bronchiolitis. However, given the complexity of the immunological mechanisms
involved, more studies are needed to confirm this association and better understand its physio-
pathological mechanism.
Supporting information
S1 Table. Technical details of multiplex PCR assays used for diagnosis from September
2008 to December 2011.
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